Why Your Early-Stage Drug Development Needs an R&D-Focused CDMO Partner

Early-stage drug development is best performed at an R&D-focused CDMO. Initial formulation and small batch manufacturing for proof-of-concept clinical trials require speed, agility, and cost-effectiveness as opposed to the scale of a Phase III or routine commercial manufacturing-focused CMO.  Preclinical work in early-stage drug development encompasses the following: These activities must generally be completed prior […]